CPT® Code 86664

The CPT® Code 86664 refers to a laboratory test that measures antibodies against the Epstein-Barr virus (EBV), specifically targeting the nuclear antigen (EBNA). This test is significant in the context of infectious mononucleosis, a viral infection commonly affecting children and young adults. The symptoms of this condition typically include fever, fatigue, sore throat, swollen lymph nodes, and in some cases, an enlarged spleen. The Epstein-Barr virus is primarily transmitted through saliva, particularly during active infection, and it has the ability to persist in the body’s lymphocytes for the lifetime of the individual, occasionally reactivating without presenting any symptoms. In addition to causing infectious mononucleosis, EBV is associated with several serious health conditions, including X-linked lymphoproliferative syndrome in males and various types of cancers such as Burkitt lymphoma, Hodgkin's lymphoma, and nasopharyngeal carcinoma. The EBNA IgG antibody test, represented by CPT® Code 86664, is utilized to document past exposure to EBV and can assist in diagnosing primary EBV infectious mononucleosis when used alongside other serological tests. It is important to note that while the early antigen (EA) IgG antibody test (CPT® Code 86663) is helpful in diagnosing acute EBV infections or reactivations, it should not be used in isolation for diagnosis. Furthermore, the EBV viral capsid antigen (VCA) test (CPT® Code 86665) evaluates IgG and IgM antibodies and is also relevant in the diagnostic process. However, the VCA test for IgA antibodies is not suitable for diagnosing infectious mononucleosis but may provide insights into the detection and prognosis of nasopharyngeal carcinoma. The blood sample required for this test is obtained through a venipuncture, and the serum is analyzed using a semi-quantitative chemiluminescent immunoassay method.